Navigation Links
Aspartame passes stiff review by European Food Safety Authority
Date:12/11/2013

(Dec. 10) The widely used no-calorie sweetener, aspartame, has been deemed safe for consumption at current levels by the European Food Safety Authority (EFSA), which conducted one of the most comprehensive risk assessments ever undertaken. EFSA's opinion echoes those of numerous government agencies, including the Food and Drug Administration. EFSA also concluded that:

  • Aspartame can be used by pregnant women.
  • Aspartame does not cause cancer, harm the brain or nervous system or affect behavior or cognitive function of children or adults.

Low and no-calorie sweeteners, including aspartame, have also been reviewed by The American Heart Association, the American Diabetes Association and the American Academy of Nutrition and Dietetics, which have found them to be safe and effective.


'/>"/>

Contact: Michael Schiferl
mschiferl@webershandwick.com
312-988-2017
Weber Shandwick
Source:Eurekalert

Page: 1

Related biology news :

1. West Nile virus passes from female to eggs, but less so from larvae to adults
2. Afterburn Fuel Review Announces the Launch of its New and Informative Website
3. Cranberries have health-promoting properties, new expert review reveals
4. New report reviews science and engineering quality at national security laboratories
5. Review outlines best practice standards for coordinator-based fracture liaison services
6. Study explores effects of review setting on scientific peer review
7. Prohormonesdirect.com Offers in Depth OxyELITE Pro Reviews
8. Fat Loss Factor Review Gives Opinion of Popular Weight Loss Program
9. Detailed Flex Belt Review and Announcement of New Discount Coupon at Flex Belt Critic Site
10. 3-D Printing and Additive Manufacturing preview issue publishing Fall 2013
11. New review sets international standards for best practice in fracture liaison services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
(Date:6/25/2020)... ... 24, 2020 , ... eClinical Solutions LLC , a ... accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) on ... severe COVID-19. This is the first study of an XPO1 inhibitor in patients ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a ... has closed on the purchase of greenfield for a new, expanded manufacturing facility. ... over 21 acres in the initial acquisition, with an option to purchase an ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader ... tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at a time ... track capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance and ... successful study, while protecting and accessing the catheter or device post-surgery is often undervalued ... Envigo in a live webinar on Wednesday, August 5, 2020 at ...
Breaking Biology Technology: